Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 1.34% vs 26.80% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -18.83% vs 196.15% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -46.90% vs 160.61% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Guangdong Jiaying Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 34.33% vs -4.44% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 1.34% vs 26.80% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 43.68% vs 411.76% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -18.83% vs 196.15% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -33.17% vs 153.09% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -46.90% vs 160.61% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -50.00% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






